Chemoprevention of Breast Cancer: The Paradox of Evidence versus Advocacy Inaction

Women who are at high risk of breast cancer can be offered chemoprevention. Chemoprevention strategies have expanded over the past decade and include selective receptor modulator inhibitors and aromatase inhibitors. Physicians are expected to provide individualized risk assessments to identify high...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Rakhshanda Layeequr, Pruthi, Sandhya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712728/
https://www.ncbi.nlm.nih.gov/pubmed/24213502
http://dx.doi.org/10.3390/cancers4041146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712728/
https://www.ncbi.nlm.nih.gov/pubmed/24213502
http://dx.doi.org/10.3390/cancers4041146

Ejemplares similares